Cardiac hypertrophy and insulin therapy in a pre-term newborn: is there a relationship?
Ital J Pediatr
; 48(1): 24, 2022 Feb 08.
Article
en En
| MEDLINE
| ID: mdl-35135591
ABSTRACT
BACKGROUND:
Hypertrophic cardiomyopathy (HCM) in newborns is a rare condition with heterogeneous etiologies. While the relationship between hyperinsulinism and cardiac hypertrophy (CH) is known, hyperinsulinism has not been reported as cause of HCM. CASE PRESENTATION We report the case of cardiac hypertrophy (CH) in an Extremely Low Birth Weight (ELBW) infant; this patient underwent insulin therapy after the onset of persistent hyperglycemia due to parenteral nutrition (PN), supporting the hypothesis of a role of iatrogenic hyperinsulinemia in the development of HCM.CONCLUSIONS:
The present case underlines the importance of a close cardiological follow-up in infants undergoing insulin infusion for an alteration in the glucose metabolism.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Hiperglucemia
/
Insulina
Límite:
Humans
/
Infant
/
Newborn
Idioma:
En
Año:
2022
Tipo del documento:
Article